[Therapy of herpetic keratitis using a new adamantan derivative].
D000328:Adult; D000362:Agar; D000368:Aged; D000547:Amantadine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D005452:Fluoresceins; D006367:HeLa Cells; D006801:Humans; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009824:Ointments; D018139:Simplexvirus / Q000187:drug effects / Q000254:growth & development; D012964:Sodium; D014776:Virus Cultivation
D005452:Fluoresceins; D009824:Ointments; D000362:Agar; D012964:Sodium; D000547:Amantadine
Zur Behandlung der Keratitis herpetica mit einem neuen Adamantan-Derivat.